e-learning
resources
Paris 2018
Wednesday, 19.09.2018
Tuberculosis transmission and screening strategies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values?
V. Sadovici-Bobeica (Chisinau, Republic of Moldova), V. Salaru (Chisinau, Republic of Moldova), L. Mazur-Nicorici (Chisinau, Republic of Moldova), M. Garabajiu (Chisinau, Republic of Moldova), T. Rotaru (Chisinau, Republic of Moldova), M. Mazur (Chisinau, Republic of Moldova)
Source:
International Congress 2018 – Tuberculosis transmission and screening strategies
Session:
Tuberculosis transmission and screening strategies
Session type:
Poster Discussion
Number:
5280
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Sadovici-Bobeica (Chisinau, Republic of Moldova), V. Salaru (Chisinau, Republic of Moldova), L. Mazur-Nicorici (Chisinau, Republic of Moldova), M. Garabajiu (Chisinau, Republic of Moldova), T. Rotaru (Chisinau, Republic of Moldova), M. Mazur (Chisinau, Republic of Moldova). Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values?. 5280
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Screening for tuberculosis in patients with rheumatic diseases commencing anti-TNF-α treatment: A regional survey
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Effectiveness of a tuberculosis screening program in rheumatic patients treated with immunossuppressants
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Screening and monitoring of TB infection in rheumatological patients on biologics therapy
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Screening and monitoring of tuberculosis in patients on biologics treatment
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach
Source: Eur Respir J 2011; 37: 231-232
Year: 2011
Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach
Source: Eur Respir J 2011; 37: 232-233
Year: 2011
Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients?
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021
Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
Clustering of patients with end-stage chronic diseases by symptoms: a new approach to identify health needs.
Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Year: 2018
Case-finding for COPD: Developing strategies to identify patients at risk populations
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Tuberculosis screening in immigrants - is it worth doing?
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005
Challenges in the prevention, diagnosis, and treatment of tuberculosis in children
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019
Quantiferon test in the complex diagnosis of tuberculosis in patients with end-stage kidney disease
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
Is tuberculosis different in elderly patients?
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept